World's Best Scientists 2026 revealed!
Mari Mino-Kenudson

Mari Mino-Kenudson

Award Badge
Best Female Scientists
2025

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Best Female Scientists 117 632 603 384 363 556 65976
Medicine 119 3833 3588 2097 1940 556 68616

Mari Mino-Kenudson publications per year

The chart shows the history of publications by Mari Mino-Kenudson between 2005 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mari Mino-Kenudson published across 21 years, from 2005 to 2025, averaging 47.2 papers a year. Output peaked at 267 publications in 2023. 128 of the 992 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 2005 to 2025. Vertical axis: number of publications, 0 to 267. Peak 267 publications in 2023. 2005: 14 publications 2006: 13 publications 2007: 14 publications 2008: 18 publications 2009: 23 publications 2010: 24 publications 2011: 37 publications 2012: 29 publications 2013: 49 publications 2014: 30 publications 2015: 24 publications 2016: 43 publications 2017: 60 publications 2018: 41 publications 2019: 34 publications 2020: 49 publications 2021: 54 publications 2022: 41 publications 2023: 267 publications 2024: 50 publications 2025: 78 publications
2005 2025

992 publications in total across all disciplines

View publications per year as a table
Mari Mino-Kenudson: publications per year, 2005 to 2025
Year Publications
2005 14
2006 13
2007 14
2008 18
2009 23
2010 24
2011 37
2012 29
2013 49
2014 30
2015 24
2016 43
2017 60
2018 41
2019 34
2020 49
2021 54
2022 41
2023 267
2024 50
2025 78
Total 992
Download as CSV

Mari Mino-Kenudson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mari Mino-Kenudson sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 541–560 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 556 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537 556
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Mari Mino-Kenudson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mari Mino-Kenudson sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 118–119 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 119 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302 119
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Mari Mino-Kenudson is affiliated with Harvard University in the United States and has a comprehensive research portfolio in medicine, with a focus on oncology and pulmonary and respiratory medicine. Their scholarly contributions span various subfields including molecular biology, cancer research, and surgery.

The scientist's publication record shows primary involvement in topics such as pancreatic and hepatic oncology research, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, cancer genomics and diagnostics, lung cancer diagnosis and treatment, medical imaging and pathology studies, and pancreatitis pathology and treatment.

Some of the recent papers authored or co-authored by Mino-Kenudson include:

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment, 2022, Nature Genetics
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers, 2020, Modern Pathology
  • Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms, 2021, Cancer Cell

Frequent co-authors who have collaborated extensively with Mino-Kenudson include Carlos Fernández-del Castillo, Justin F. Gainor, Yin P. Hung, David T. Ting, and Jaimie L. Barth.

The scientist's work has been published predominantly in notable journals such as the Journal of Thoracic Oncology, Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Histopathology, and Gastroenterology.

Mari Mino-Kenudson's research impact is reflected in their extensive publication count within the main fields of medicine and biochemistry, genetics, and molecular biology. Their research addresses critical areas in oncology, particularly involving lung and pancreatic cancer, combining clinical and molecular approaches to improve understanding and treatment.

Best Publications

  • Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  • Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

    Lecia V. Sequist;Belinda A. Waltman;Dora Dias-Santagata;Subba Digumarthy

  • Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Alice T. Shaw;Beow Y. Yeap;Mari Mino-Kenudson;Subba R. Digumarthy

  • ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

    Kristin Bergethon;Alice T. Shaw;Sai Hong Ignatius Ou;Ryohei Katayama

  • Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

    Richard Possemato;Kevin M. Marks;Yoav D. Shaul;Michael E. Pacold

  • International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.

    Tooru Shimosegawa;Suresh T. Chari;Luca Frulloni;Terumi Kamisawa

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

    Jean Nicolas Vauthey;Timothy M. Pawlik;Dario Ribero;Tsung Teh Wu

  • Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

    Ryohei Katayama;Alice T. Shaw;Alice T. Shaw;Tahsin M. Khan;Tahsin M. Khan;Mari Mino-Kenudson

  • Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

    Justin F. Gainor;Leila Dardaei;Satoshi Yoda;Luc Friboulet

  • EGFR Mutations and ALK Rearrangements Are Associated With Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis

    Justin F. Gainor;Alice T. Shaw;Lecia V. Sequist;Xiujun Fu

  • EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

    Ryan B. Corcoran;Hiromichi Ebi;Alexa B. Turke;Erin M. Coffee

  • Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

    Christina Pfirschke;Camilla Engblom;Steffen Rickelt;Virna Cortez-Retamozo

  • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

    Scott J. Rodig;Mari Mino-Kenudson;Sanja Dacic;Beow Y. Yeap

  • mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake

    Ömer H. Yilmaz;Pekka Katajisto;Dudley W. Lamming;Yetis Gültekin;Yetis Gültekin

  • Patient-derived models of acquired resistance can identify effective drug combinations for cancer

    Adam S. Crystal;Alice T. Shaw;Lecia V. Sequist;Luc Friboulet

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer

    Justin F. Gainor;Anna M. Varghese;Sai-Hong Ignatius Ou;Sheheryar Kabraji

  • RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

    Matthew J. Niederst;Lecia V. Sequist;John T. Poirier;Craig H. Mermel

  • Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure

    Cristina R. Ferrone;Rafael Pieretti-Vanmarcke;Jordan P. Bloom;Hui Zheng

Frequent Co-Authors

William R. Brugge
William R. Brugge Harvard University
Andrew L. Warshaw
Andrew L. Warshaw Harvard University
Keith D. Lillemoe
Keith D. Lillemoe Harvard University
Jeffrey A. Engelman
Jeffrey A. Engelman Novartis Institutes for BioMedical Research (NIBR)
Alice T. Shaw
Alice T. Shaw Harvard University
Gregory Y. Lauwers
Gregory Y. Lauwers Harvard University
Cristina R. Ferrone
Cristina R. Ferrone Harvard University
Justin F. Gainor
Justin F. Gainor Harvard University
A. John Iafrate
A. John Iafrate Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in the medical field but not committed to a traditional path like medical school, a range of online degrees and alternative career pathways are available. Many choose direct entry nurse practitioner programs for non-nurses online, which allow those with non-nursing bachelor’s degrees to become advanced practice nurses through accelerated study.

For those seeking shorter or more accessible options, some online adn programs provide a path to becoming a registered nurse. These programs typically feature flexible admission requirements and are designed for people at different educational backgrounds.

Not all roles in healthcare require clinical training. Careers in health administration and technology are growing fast. For example, you might consider medical billing and coding schools online to enter a vital part of healthcare operations, often with remote work possibilities.

Finally, some nursing programs make entry easier by eliminating standardized entrance tests. Consider applying to a nursing school that doesn't require teas, reducing the barriers to starting your health care journey.

Best Scientists Citing Mari Mino-Kenudson

Trending Scientists

Recently Published Articles